But promising results from a small clinical trial for an mRNA pancreatic cancer vaccine are fueling new rays of hope. “The latest data from the Phase I trial are encouraging,” said lead author ...

Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...

A recent study found that mRNA-based vaccines may help to delay the recurrence of pancreatic cancer by generating long-lasting immune responses. The phase 1 trial results, published Feb. 19 in ...

“The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of pancreatic cancer: hope,” Jarvis writes.

A PDAC cell line was generated from a patient who consented to make the genetic code of her cancer cells publicly available ...

Beyond mRNA-based diagnostic tests, mRNA has also shown early promise as a therapy for cancer patients, enabling personalized treatment that could more effectively target one’s tumor.

An mRNA-based diagnostic test is being developed that could catch cancers earlier, when they're more treatable. But this innovation is under threat. News Sports Indy 500 Things To Do Opinion ...

In the study, researchers wanted to know what allowed cells to survive in one place instead of the other. To do this, they analyzed data from MetMap, a project at the Broad Institute, an independent ...

Pancreatic cancer is one of the deadliest cancers. But those battling the disease saw promising results in the small clinical trial of an mRNA vaccine.

Yet today, that consensus is showing signs of strain. State legislatures across the country are advancing bills to ban or severely restrict the use of – and further research into – breakthrough ...